These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8683634)

  • 1. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
    Gelber RD; Goldhirsch A; Cole BF; Wieand HS; Schroeder G; Krook JE
    J Natl Cancer Inst; 1996 Aug; 88(15):1039-45. PubMed ID: 8683634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
    Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
    N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
    DeCosse JJ; Cennerazzo WJ
    J Natl Cancer Inst; 1996 Nov; 88(22):1686. PubMed ID: 8931615
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer.
    Cafiero F; Gipponi M; Peressini A; Bertoglio S; Lionetto R
    J Surg Oncol; 2000 Oct; 75(2):80-8. PubMed ID: 11064385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
    Gelber RD; Cole BF; Goldhirsch A; Rose C; Fisher B; Osborne CK; Boccardo F; Gray R; Gordon NH; Bengtsson NO; Sevelda P
    Lancet; 1996 Apr; 347(9008):1066-71. PubMed ID: 8602056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
    Fisher B; Wolmark N; Rockette H; Redmond C; Deutsch M; Wickerham DL; Fisher ER; Caplan R; Jones J; Lerner H
    J Natl Cancer Inst; 1988 Mar; 80(1):21-9. PubMed ID: 3276900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life-adjusted survival analysis of concurrent chemo radiotherapy for locally advanced (nonmetastatic) nasopharyngeal cancer.
    Gao F; Wee J; Wong HB; Machin D
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):454-60. PubMed ID: 20092962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival.
    Gelber RD; Cole BF; Goldhirsch A; Bonadonna G; Howell A; McArdle CS; Mouridsen HT; Rubens RD; Welvaart K
    Cancer J Sci Am; 1995; 1(2):114-21. PubMed ID: 9166464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of adjuvant chemotherapy in stage C (III) rectal cancer: comparison of data from matched patients in a teaching hospital's clinico-pathological database.
    Kho P; Chapuis PH; Beale P; Bokey L; Dent OF; Clarke S
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):346-55. PubMed ID: 22897797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
    Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
    Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative radiotherapy in the combination of adjuvant chemotherapy for the treatment of pT3N0M0 rectal cancer after radical surgery.
    Zhang Q; Tey J; Yang Z; Li P; Peng L; Jiang R; Xiong F; Fu S; Lu JJ
    Am J Clin Oncol; 2014 Feb; 37(1):8-12. PubMed ID: 22892433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy in rectal cancer].
    Schmoll HJ
    Chirurg; 1994 Jul; 65(7):576-84. PubMed ID: 7924595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.